Quoin Pharmaceuticals prices $6.8M public offering of ADSs and warrants

Quoin Pharmaceuticals, Ltd.

Gross proceeds ~$6.8M from offering of 15,111,110 ADSs (or pre-funded warrants) and Series F/G warrants at $0.45 per unit.
Series F warrants (2-yr expiry) and Series G warrants (5-yr expiry) each have exercise price of $0.45 per ADS.
Prior warrants for up to 7,002,500 ADSs amended: exercise price reduced to $0.45 from $1.60, expiry extended to Dec 2029.
Company officers and directors purchased ~$600K of ADSs and warrants in the offering.
Net proceeds to be used for general corporate purposes, including R&D and working capital.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.